![Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation - Multiple Sclerosis and Related Disorders Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/007fba65-3edf-4665-8f1b-b5897dd536dc/gr1.jpg)
Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation - Multiple Sclerosis and Related Disorders
![PDF) Author(s) Employee Satisfaction and Work Motivation – Research in Prisma Mikkeli | Varsha Pandey - Academia.edu PDF) Author(s) Employee Satisfaction and Work Motivation – Research in Prisma Mikkeli | Varsha Pandey - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/34140871/mini_magick20180817-13030-1ul91bo.png?1534543822)
PDF) Author(s) Employee Satisfaction and Work Motivation – Research in Prisma Mikkeli | Varsha Pandey - Academia.edu
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma:
![RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group | SpringerLink RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-019-03815-7/MediaObjects/277_2019_3815_Fig2_HTML.png)